Reactivation of hepatitis B refers to the abrupt increase in hepatitis B virus (HBV) replication
in a patient with inactive or resolved hepatitis B. Reactivation can occur spontaneously, but …

Chronic hepatitis B is caused by persistent infection with the hepatitis B virus (HBV), a
unique DNA virus that replicates through an RNA intermediate produced from a stable …

Purpose Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication
in cancer patients with chronic HBV (hepatitis B surface antigen [HBsAg] positive) …

Background Rituximab has been associated with hepatitis B virus reactivation (HBV-R).
However, the characteristics and scope of this association remain largely undefined …

The prevalence of hepatitis B virus (HBV) infection in patients with haematological
malignancies is increased compared with the general population worldwide. HBV …

Background: Rituximab has increasingly been used for the treatment of hematological
malignancies and autoimmune diseases, and its efficacy and safety are well established …

Hepatitis B virus (HBV) reactivation is a well-known complication of lymphoma treatment in
the pre-rituximab era. This complication has not been as well studied, however, since …

Recently, a human/mouse chimeric monoclonal antibody, rituximab, has been successfully
used to treat cases of B-cell non-Hodgkin's lymphoma and some autoimmune diseases …

B cells play an important role in the clearance of hepatitis B virus (HBV) and protection
against reinfection. However, the functional characteristics of these cells that are associated …

Rituximab, an anti CD20 monoclonal antibody, has now become a cornerstone in the
treatment of many CD20 positive hematological malignancies and a variety of autoimmune …